Thorne
Provider of nutritional supplements, health diagnostics technology platforms, and medical education.
Launch date
Employees
Market cap
$551m
Enterprise valuation
$609m (Public information from Oct 2023)
Share price
$10.19 THRN
New York City New York (HQ)
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Revenues | 103m | 138m | 185m | 229m | 288m | 368m |
% growth | - | 35 % | 34 % | 23 % | 26 % | 28 % |
EBITDA | (9.6m) | 5.1m | 15.7m | 10.3m | - | - |
% EBITDA margin | (9 %) | 4 % | 8 % | 5 % | - | - |
Profit | (16.7m) | (3.4m) | 7.3m | 15.7m | - | - |
% profit margin | (16 %) | (2 %) | 4 % | 7 % | - | - |
R&D budget | 3.9m | 4.2m | 5.9m | 7.4m | - | - |
R&D % of revenue | 4 % | 3 % | 3 % | 3 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Growth Equity VC | ||
N/A | - | ||
N/A | $70.0m Valuation: $525m 3.8x EV/LTM Revenues 103.6x EV/LTM EBITDA | IPO | |
* | $680m Valuation: $680m 3.0x EV/LTM Revenues 66.0x EV/LTM EBITDA | Acquisition | |
Total Funding | - |
Recent News about Thorne
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Thorne
EditACQUISITION by Thorne Feb 2023